Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules

被引:874
作者
Kirk, Kenneth L. [1 ]
机构
[1] NIDDK, Bioorgan Chem Lab, NIH, DHHS, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
fluorinated drugs; central nervous system; metabolic disorders; cardiovascular disease; antibacterial agents; antifungal therapy;
D O I
10.1016/j.jfluchem.2006.06.007
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Advances in the development of newly developed fluorinated drugs, approved or in clinical trials, as organized by biological targets/disease states, are reviewed. In a few cases, compounds in early stages of development will be discussed, particularly where new promising targets are involved. Important topics such as anticancer and antiviral drugs were covered in the two previous reviews in this series. Included herein will be fluorinated drugs for treatment of diseases of the central nervous system, various cardiovascular diseases and obesity, antibacterial agents, and antifungal therapy. Published by Elsevier B.V.
引用
收藏
页码:1013 / 1029
页数:17
相关论文
共 96 条
  • [1] Development of the quinolones
    Andersson, MI
    MacGowan, AP
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 : 1 - 11
  • [2] Dipeptidyl peptidase IV inhibitors derived from β-aminoacylpiperidines bearing a fused thiazole, oxazole, isoxazole, or pyrazole
    Ashton, WT
    Sisco, RM
    Hong, D
    Lyons, KA
    He, HB
    Doss, GA
    Leiting, B
    Patel, RA
    Wu, JK
    Marsilio, F
    Thornberry, NA
    Weber, AE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2253 - 2258
  • [3] Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1)
    Bächner, D
    Kreienkamp, HJ
    Weise, C
    Buck, F
    Richter, D
    [J]. FEBS LETTERS, 1999, 457 (03) : 522 - 524
  • [4] Balfour JAB, 2000, DRUGS, V59, P115
  • [5] Oxazolidinone structure-activity relationships leading to linezolid
    Barbachyn, MR
    Ford, CW
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (18) : 2010 - 2023
  • [6] PPARδ:: a dagger in the heart of the metabolic syndrome
    Barish, GD
    Narkar, VA
    Evans, RM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) : 590 - 597
  • [7] BIOLOGICAL ISSUES IN SCHIZOPHRENIA
    BARNES, DM
    [J]. SCIENCE, 1987, 235 (4787) : 430 - 433
  • [8] Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease
    Barter, PJ
    Kastelein, JJP
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (03) : 492 - 499
  • [9] THE CONVERGENT SYNTHESIS OF CI-981, AN OPTICALLY-ACTIVE, HIGHLY POTENT, TISSUE SELECTIVE INHIBITOR OF HMG-COA REDUCTASE
    BAUMANN, KL
    BUTLER, DE
    DEERING, CF
    MENNEN, KE
    MILLAR, A
    NANNINGA, TN
    PALMER, CW
    ROTH, BD
    [J]. TETRAHEDRON LETTERS, 1992, 33 (17) : 2283 - 2284
  • [10] BEGUE JP, IN PRESS J FLUORINE